KalshiComprobar disponibilidadKYC requeridoDatos de resolución verificadosBien calibradoPunto medio del libro seleccionado
Before 2027 · —
Cargando el libro seleccionado…
—
Precio guardado
Before 2027 20.5%Líder entre 3 opciones
Before 2027 20.5%Calidad del mercado
62 / 100
Calidad mediaVolumen 24h
89,2 €
Interés abierto
41,7 mil US$
Interés abierto altoCompra / Venta
— / —
Before 2027Spread
—
Datos de mercado
Actualizado hace 7 minutos
24 mar 26, 14:00 UTC1 nov 26, 4:59 UTC
El gráfico y los cambios muestran probabilidades históricas guardadas, no el libro seleccionado en directo.
Tendencias
Fila seleccionada: punto medio del libro. Otras filas: referencias guardadas, posiblemente normalizadas; los cambios de 24h usan el historial guardado.
Before SeptemberPerdida
Condiciones de la plataforma
Fuente: Kalshi
Estas condiciones son informativas; las operaciones simuladas de CoinRithm siguen sus propias reglas.
- Cierre anticipado:
- Sí
- Plazo de liquidación:
- 30m (informativo)
Profundidad de mercado · Before 2027
Cargando el libro seleccionado…
—
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Is Cheryl Scott from ABC CHICAGO pregnant????!?!??? 🤰
Manifold MarketsAnthropic lab leak by which date?
PolymarketSkin cancer vaccine BLA submitted by which date?
PolymarketHantavirus pandemic in 2026?
PolymarketCan the son do more push-ups than the father?
Manifold MarketsNew pandemic before 2028?
PolymarketReglas
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
Liquida mediante:Food and Drug Administration
- The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
Reglas de cada resultado
- Before 2027
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
- Before November
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.
- Before September
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.